ZIOPHARM Oncology, Inc. (ZIOP) Posts Q2 Loss of 29c/Share
Tweet Send to a FriendGet Alerts ZIOP Hot Sheet
Price: $1.71 -4.47%
Revenue Growth %: 0.0%
Financial Fact:
General and administrative: 4.67M
Today's EPS Names:
NED, OESX, WSTL, More
Revenue Growth %: 0.0%
Financial Fact:
General and administrative: 4.67M
Today's EPS Names:
NED, OESX, WSTL, More
Trade ZIOP Now!
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q2 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $150 thousand.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- LTX-Credence Corp (LTXC) Misses Q3 EPS by 2c; Issues Weak Q4 Outlook
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
